ClinicalTrials.gov record
Recruiting Phase 3 Interventional

REGN7508 Versus Apixaban and Enoxaparin for Thromboprophylaxis After Total Knee Arthroplasty in Adults

ClinicalTrials.gov ID: NCT07015905

Public ClinicalTrials.gov record NCT07015905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:11 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Open-Label, Study to Evaluate REGN7508, A Factor XI Monoclonal Antibody, Versus Apixaban and Enoxaparin for Prophylaxis of Venous Thromboembolism After Elective Total Knee Arthroplasty (ROXI-APEX)

Study identification

NCT ID
NCT07015905
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Regeneron Pharmaceuticals
Industry
Enrollment
2,000 participants

Conditions and interventions

Interventions

  • Apixaban Drug
  • Enoxaparin Drug
  • Placebo Drug
  • REGN7508 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 24, 2025
Primary completion
Feb 19, 2027
Completion
May 11, 2027
Last update posted
May 5, 2026

2025 – 2027

United States locations

U.S. sites
19
U.S. states
11
U.S. cities
19
Facility City State ZIP Site status
Shoals Medical Trials, Inc. Sheffield Alabama 35660 Recruiting
CARI Clinical Trials Riverside California 92504 Recruiting
Denver Metro Orthopedics, P.C. Englewood Location Englewood Colorado 80113 Recruiting
Delray Physician Care Center Delray Beach Florida 33445 Recruiting
Bioresearch Partner Miami Florida 33175 Recruiting
Sacred Heart Health System Inc Pensacola Florida 32504 Recruiting
Gulfcoast Research Institute Sarasota Florida 34232 Recruiting
Phoenix Clinical Research Tamarac Florida 33321 Recruiting
Sinai Hospital of Baltimore, Inc. Baltimore Maryland 21215 Recruiting
Brigham and Women's Hospital Boston Massachusetts 02115 Recruiting
Curalta Clinical Trials Westwood New Jersey 07675 Recruiting
Duke University Health System (Duke Health), Duke University Hospital Durham North Carolina 27710 Recruiting
Keystone Clinical Studies LLC, dba Flourish Research Plymouth Meeting Pennsylvania 19462 Recruiting
HD Research - First Surgical Hospital Bellaire Texas 77401 Recruiting
University of Texas (UT); Southwestern Medical Center Dallas Texas 75390 Recruiting
NextStage Clinical Research, All American Orthopedics and Sports Medicine Houston Texas 77058 Recruiting
Futuro Clinical Trials McAllen Texas 78501 Recruiting
Flourish Research - San Antonio (Formerly Clinical Trials of Texas) San Antonio Texas 78229 Recruiting
DRx Clinical Research, LLC St. George Utah 84770 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 25 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07015905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 5, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07015905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →